-DOCSTART-	
	
Mitochondrial	B-Material
aminoacyl	I-Material
-	I-Material
	
tRNA	I-Material
synthetases	I-Material
(	I-Material
aaRSs	I-Material
)	I-Material
are	O
essential	B-Material
enzymes	I-Material
in	O
protein	B-Process
synthesis	I-Process
since	O
they	O
charge	O
tRNAs	B-Material
with	O
their	B-Material
cognate	I-Material
amino	I-Material
acids	I-Material
.	O
	
Mutations	B-Process
in	O
the	B-Material
genes	I-Material
encoding	B-Process
mitochondrial	B-Material
aaRSs	I-Material
have	O
been	O
associated	O
with	O
a	B-Process
wide	I-Process
spectrum	I-Process
of	I-Process
human	I-Process
mitochondrial	I-Process
diseases	I-Process
.	O
	
Here	O
we	O
report	O
the	B-Process
identification	I-Process
of	O
pathogenic	B-Process
mutations	I-Process
(	O
a	B-Process
partial	I-Process
genomic	I-Process
deletion	I-Process
and	O
a	B-Material
highly	I-Material
conserved	I-Material
p.	I-Material
Asp325Tyr	I-Material
missense	I-Material
variant	I-Material
)	O
in	O
FARS2	B-Material
,	O
the	B-Material
gene	I-Material
encoding	I-Material
mitochondrial	I-Material
phenylalanyl	I-Material
-	I-Material
tRNA	I-Material
synthetase	I-Material
,	O
in	O
a	B-Material
patient	I-Material
with	O
early	B-Process
-	I-Process
onset	I-Process
epilepsy	I-Process
and	O
isolated	B-Process
complex	I-Process
IV	I-Process
deficiency	I-Process
in	O
muscle	B-Material
.	O
	
The	B-Data
biochemical	I-Data
defect	I-Data
was	O
expressed	O
in	O
myoblasts	B-Material
but	O
not	O
in	O
fibroblasts	B-Material
and	O
associated	O
with	O
decreased	B-Data
steady	I-Data
state	I-Data
levels	I-Data
of	O
COXI	B-Material
and	I-Material
COXII	I-Material
protein	I-Material
and	O
reduced	B-Data
steady	I-Data
state	I-Data
levels	I-Data
of	O
the	B-Material
mt	I-Material
-	I-Material
tRNAPhe	I-Material
transcript	I-Material
.	O
	
Functional	O
analysis	O
of	O
the	B-Material
recombinant	I-Material
mutant	I-Material
p.	I-Material
Asp325Tyr	I-Material
	
FARS2	I-Material
	
protein	I-Material
showed	O
an	O
inability	O
to	O
bind	B-Process
ATP	B-Material
and	O
consequently	O
undetectable	B-Process
aminoacylation	I-Process
activity	I-Process
using	O
either	B-Material
bacterial	I-Material
tRNA	I-Material
or	I-Material
human	I-Material
mt	I-Material
-	I-Material
tRNAPhe	I-Material
as	O
substrates	B-Material
.	O
	
Lentiviral	B-Process
transduction	I-Process
of	O
cells	B-Material
with	O
wildtype	B-Data
FARS2	I-Data
restored	I-Data
complex	I-Data
IV	I-Data
protein	I-Data
levels	I-Data
,	O
confirming	O
that	O
the	B-Process
p	I-Process
.	I-Process
	
Asp325Tyr	I-Process
mutation	I-Process
is	O
pathogenic	B-Process
,	O
causing	O
respiratory	B-Process
chain	I-Process
deficiency	I-Process
and	O
neurological	B-Data
deficits	I-Data
on	O
account	O
of	O
defective	B-Process
aminoacylation	I-Process
of	O
mt	B-Material
-	I-Material
tRNAPhe	I-Material
.	O
	
Highlights	O
•	O
	
The	B-Data
tissue	I-Data
specific	I-Data
variation	I-Data
in	O
presentation	O
of	O
aaRS	B-Process
mutations	I-Process
is	O
discussed	O
.	O
	
•	O
	
A	O
further	O
clinical	O
presentation	O
of	O
a	B-Data
FARS2	I-Data
defect	I-Data
.	O
	
•	O
	
Molecular	B-Process
mechanism	I-Process
of	O
FARS2	B-Data
defect	I-Data
is	O
characterised	O
in	B-Method
vitro	I-Method
.	O
	
